Clinical Trial Update: Safety, Tolerability and Blood Sampling of GSK3923868 Administered Via Dry Powder Inhaler to Healthy Participants of Chinese, Japanese and European Ancestry [Phase 1]

View source ↗

Summary

A Phase 1 study assessing safety, tolerability, and blood sampling of inhaled GSK3923868 in healthy participants of Chinese, Japanese, and European ancestry; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infection

Drugs mentioned

• GSK3923868 (GSK3923868)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Respiratory Tract Infections | Phase 1 | Status: COMPLETED